Sonnet BioTherapeutics Stock Quote SONN - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.898

Bid

0.8805

Ask

0.93

Volume

8,949

0.88 Day's Range 0.9101

0.8705 52 Week Range 12.10

Market Cap

2.801M

Previous Close

0.88

Open

0.905

Last Trade

0.9

Last Trade Time

Financial Volume

$ 8,060

VWAP

0.900609

Average Volume (3m)

35,892

Shares Outstanding

3,112,401

Dividend Yield

PE Ratio

-0.15

Earnings Per Share (EPS)

-6.05

Revenue

148k

Net Profit

-18.83M

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. Show more

Sector

Pharmaceutical Preparations

Industry

Management Consulting Svcs

Website

www.sonnetbio.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SONN. The last closing price for Sonnet BioTherapeutics was $0.88. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of $ 0.8705 to $ 12.10.

Sonnet BioTherapeutics currently has 3,112,401 shares outstanding. The market capitalization of Sonnet BioTherapeutics is $2.80 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.15.

Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds

PRINCETON, N.J., June 20, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing targeted immunotherapeutic...

Form 8-K - Current report

Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain

Sonnet discovered and characterized a modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.022	-2.39130434783	0.92	0.959999	0.8711	45230	0.92173343	CS
4	-0.742	-45.243902439	1.64	2	0.8705	66332	1.13499182	CS
12	-1.052	-53.9487179487	1.95	2.1	0.8705	35892	1.37157068	CS
26	-0.842	-48.3908045977	1.74	2.3399	0.8705	69950	1.80721153	CS
52	-10.542	-92.1503496503	11.44	12.1	0.8705	350515	6.96095863	CS
156	-464.182	-99.8069149394	465.08	637.56	0.8705	2844865	137.20816223	CS
260	-1914.862	-99.9531256525	1915.76	4989.6	0.8705	2500683	329.49133607	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
KOSSKoss Corporation	$ 10.63 (143.81%)	70.06M
JEWLAdamas One Corporation	$ 0.4615 (89.14%)	6.58M
VVPRVivoPower International PLC	$ 2.50 (66.67%)	55.79M
DOYUDouYu International Holdings Ltd	$ 17.94 (42.49%)	5.25M
AHGAkso Health Group	$ 1.155 (40.51%)	520k
SHPWShapeways Holdings Inc	$ 0.2693 (-61.86%)	1.99M
SONMSonim Technologies Inc	$ 0.5507 (-42.34%)	1.47M
SHOTWSafety Shot Inc	$ 0.18 (-35.71%)	2.01k
AMIXAutonomix Medical Inc	$ 0.6415 (-31.76%)	19.59M
VIVKVivakor Inc	$ 2.31 (-31.66%)	368.29k
NVDANVIDIA Corporation	$ 128.28 (4.57%)	215.8M
ZCARZoomcar Holdings Inc	$ 0.183 (33.97%)	204.3M
MAXNMaxeon Solar Technologies Ltd	$ 0.1736 (-3.50%)	202.28M
TSLATesla Inc	$ 246.39 (6.54%)	166.56M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 14.02 (13.16%)	86.38M